Akston’s AKS-699 Demonstrates One-Year Pruritus Control with Fewer Treatments
BEVERLY, Mass., June 16, 2026 Akston Biosciences Corporation has announced promising preclinical data demonstrating that its investigational immunotherapeutic AKS-699...
chronic pain treatment
Advertisement
SonoClear Study Selected for EANS 2026 Oral Presentation
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
Nervonik Completes First Human Nerve Sensing Study
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
Vertanical’s Exilby Wins First European Approval for Chronic Pain
GRÄFELFING, Germany – June 9, 2026 VERTANICAL has achieved a major milestone in chronic pain treatment after receiving Germany’s...
Yuka Report Highlights Ultra-Processed Food Crisis
NEW YORK, May 27, 2026 Yuka, the independent food and cosmetic scoring application used by more than 85 million...
Advertisements
Consano Bio Starts Phase 1 Trial for C-1101 Therapy
BURLINGTON, Massachusetts, May 26, 2026 Consano Bio, Inc., a clinical-stage biotechnology company focused on developing innovative therapies for painful...
Whitehawk Expands ADC Cancer Therapy Pipeline
MORRISTOWN, N.J., May 21, 2026 Whitehawk Therapeutics has announced a major expansion of its antibody-drug conjugate (ADC) oncology pipeline...
Medtronic to Acquire SPR Therapeutics for Pain Care
GALWAY, Ireland, May 20, 2026 Medtronic plc has announced its intent to acquire SPR Therapeutics, Inc. in a deal...
Advertisement
